Report ID : 1289275 | Published : June 2025 | Study Period : 2023-2033 | Format : PDF + Excel
The market size of the Alopecia (Hair Loss Treatment) Market is categorized based on Treatment Type (Topical Treatments, Oral Medications, Hair Transplantation, Low-Level Laser Therapy, Platelet-Rich Plasma Therapy) and End User (Hospitals, Dermatology Clinics, Home Care, Specialty Clinics, Online Pharmacies) and Gender (Male, Female) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).
The Alopecia (Hair Loss Treatment) Market size was valued at $8.5 billion in 2023 and is projected to reach $16.2 billion by 2033, growing at a CAGR of 7.1% from 2024 to 2033. This report includes various market segments and analyzes the key trends and factors influencing market growth.
The Alopecia market which includes a variety of hair loss remedies is widening in scope due to the increasing concern towards hair and its aesthetics around the globe. Alopecia is more than an aesthetic problem; it has a multitude of psychological factors alongside it. With such conditions becoming more common, consumers and vice versa, are in tandem searching for better and resolving solutions resulting in further medical and clinical advances. Be it ointments, capsules or therapy, the existing one is shifting to accommodate the more varied populace suffering from loss of hair.
In addition, the growth of alopecia which is considered hereditary, hormonal and or alternatively induced is making the need for specialized goods and services even stronger. Technology infusion and comprehending the fundamentals within the alopecia scope are some of the tactics and methods being adopted, by R&D within the sector. This has resulted in the Alopecia sector being more competitive than before as market tools within the sector have one aim, and that is to decrease the physical effects caused by the loss of hairs and improve the psychological aspect of it.
ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2023-2033 |
BASE YEAR | 2023 |
FORECAST PERIOD | 2024-2033 |
HISTORICAL PERIOD | 2023-2024 |
UNIT | VALUE (USD BILLION) |
KEY COMPANIES PROFILED | Rogaine (Johnson & Johnson), Propecia (Merck & Co. Inc.), Bosley, Hims Inc., Keeps, DHC Corporation, Aderans Company Limited, HairMax, P&G (Procter & Gamble), Reviva Labs, Crown Aesthetics |
SEGMENTS COVERED |
By Treatment Type - Topical Treatments, Oral Medications, Hair Transplantation, Low-Level Laser Therapy, Platelet-Rich Plasma Therapy By End User - Hospitals, Dermatology Clinics, Home Care, Specialty Clinics, Online Pharmacies By Gender - Male, Female By Geography - North America, Europe, APAC, Middle East Asia & Rest of World. |
The Alopecia (Hair Loss Treatment) Market is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.
This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.
Verified Industry Insights offers one of the following report customization options to our respectable clients :
● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)
● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.
Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439
© 2024 Verified Industry Insights. All Rights Reserved